Home > Insider Trading > Filing (0001209191-19-025236)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1661567	Michael Parini	50 Northern Avenue Boston MA 02210	Evp, Cl&Ao	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-04-16	4,250	$122.45	39,253	No	4	M	Direct
Common Stock	Disposition	2019-04-16	870	$179.91	38,383	No	4	S	Direct
Common Stock	Disposition	2019-04-16	815	$181.31	37,568	No	4	S	Direct
Common Stock	Disposition	2019-04-16	1,605	$182.19	35,963	No	4	S	Direct
Common Stock	Disposition	2019-04-16	300	$183.26	35,663	No	4	S	Direct
Common Stock	Disposition	2019-04-16	660	$184.44	35,003	No	4	S	Direct
Common Stock	Acquisiton	2019-04-16	2,125	$90.29	37,128	No	4	M	Direct
Common Stock	Disposition	2019-04-16	425	$179.84	36,703	No	4	S	Direct
Common Stock	Disposition	2019-04-16	600	$181.49	36,103	No	4	S	Direct
Common Stock	Disposition	2019-04-16	600	$182.24	35,503	No	4	S	Direct
Common Stock	Disposition	2019-04-16	100	$183.15	35,403	No	4	S	Direct
Common Stock	Disposition	2019-04-16	400	$184.42	35,003	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2019-04-16	4,250	$0.00	4,250	$122.45
Common Stock	Stock Option (Right to Buy)	Disposition	2019-04-16	2,125	$0.00	2,125	$90.29

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
12,750		2026-01-03	No	4	M	Direct
10,625		2026-07-11	No	4	M	Direct

Footnotes

Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $179.91 (range $179.68 to $180.55).
Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $181.31 (range $180.82 to $181.67).
Open market sales reported on this line occurred at a weighted average price of $182.19 (range $181.84 to $182.67).
Open market sales reported on this line occurred at a weighted average price of $183.26 (range $183.13 to $183.48).
Open market sales reported on this line occurred at a weighted average price of $184.44 (range $184.18 to $184.71).
Open market sales reported on this line occurred at a weighted average price of $179.84 (range $179.63 to $180.30).
Open market sales reported on this line occurred at a weighted average price of $181.49 (range $180.97 to $181.95).
Open market sales reported on this line occurred at a weighted average price of $182.24 (range $182.06 to $182.53).
Open market sales reported on this line occurred at a weighted average price of $184.42 (range $184.18 to $184.71).
The option vests in 16 quarterly installments from 1/4/2016.
The option vests in 16 quarterly installments from 7/12/2016.